Related Experiment Video
Updated: Jul 3, 2025

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Clonal Expansion in Cardiovascular Pathology
Alexander Lin1,2, Mairi Brittan3, Andrew H Baker3,4
1Atherosclerosis and Vascular Remodeling Group, Heart Research Institute, Sydney, New South Wales, Australia.
Insights
Clonal expansion of vascular cells is observed across many cardiovascular diseases, suggesting stem-like cells drive disease progression. Understanding and targeting these clones may offer novel therapeutic strategies for cardiovascular conditions.
Area of Science:
- Cardiovascular Biology
- Cellular Clonality
- Disease Pathogenesis
Background:
- Clonal expansion, the Darwinian proliferation and selection of advantageous cell clones, is increasingly recognized in cardiovascular diseases.
- While cell clonality in the cardiovascular system is better understood, the mechanisms driving clonal selection remain largely unknown.
- A common pattern of clonal expansion involving smooth muscle cells, endothelial cells, and macrophages is observed across diverse cardiovascular pathologies.
Purpose of the Study:
- To comprehensively review current knowledge on clonal expansion in the cardiovascular field.
- To explore the potential existence and role of stem-like vascular cells in disease.
- To evaluate the clinical implications of targeting clonal cells for therapeutic interventions.
Main Methods:
- Review of existing literature on clonal expansion in cardiovascular diseases.
- Comparative analysis of clonal cell behavior in atherosclerosis, pulmonary hypertension, aneurysm, and other conditions.
- Discussion of potential therapeutic strategies targeting clonal vascular cells.
Main Results:
- Clonal expansion of vascular cells is a recurring theme in various cardiovascular diseases, regardless of microenvironment.
- Evidence suggests the presence of disease-primed, stem-like vascular cells contributing to clonal expansion.
- Phenotypic changes in subsequent clones can result in either protective or detrimental roles.
Conclusions:
- Investigating clone-forming vascular cells offers insights into disease mechanisms.
- Harnessing the inherent clonal nature of vascular cells presents potential therapeutic avenues.
- Targeting specific clonal cells may lead to unique treatment options for cardiovascular diseases.
Abstract:
Clonal expansion refers to the proliferation and selection of advantageous "clones" that are better suited for survival in a Darwinian manner. In recent years, we have greatly enhanced our understanding of cell clonality in the cardiovascular context. However, our knowledge of the underlying mechanisms behind this clonal selection is still severely limited. There is a transpiring pattern of clonal expansion of smooth muscle cells and endothelial cells-and, in some cases, macrophages-in numerous cardiovascular diseases irrespective of their differing microenvironments. These findings indirectly suggest the possible existence of stem-like vascular cells which are primed to respond during disease. Subsequent clones may undergo further phenotypic changes to adopt either protective or detrimental roles. By investigating these clone-forming vascular cells, we may be able to harness this inherent clonal nature for future therapeutic intervention. This review comprehensively discusses what is currently known about clonal expansion across the cardiovascular field. Comparisons of the clonal nature of vascular cells in atherosclerosis (including clonal hematopoiesis of indeterminate potential), pulmonary hypertension, aneurysm, blood vessel injury, ischemia- and tumor-induced angiogenesis, and cerebral cavernous malformations are evaluated. Finally, we discuss the potential clinical implications of these findings and propose that proper understanding and specific targeting of these clonal cells may provide unique therapeutic options for the treatment of these cardiovascular conditions.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cells of the Adaptive Immune Response

